Epinastine hydrochloride for atopic disease

Drugs of Today

Volumn 40, Issue 8, 2004, Pages 677-683

  Fraunfelder, Frederick W ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b CASEY EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL NICOTINATE; AMOXICILLIN; AMPICILLIN; ANTIHISTAMINIC AGENT; ASCORBIC ACID; BECLOMETASONE DIPROPIONATE; EPINASTINE; ETHINYLESTRADIOL; ETIZOLAM; FAMOTIDINE; FLUTICASONE PROPIONATE; GLIBENCLAMIDE; IFENPRODIL TARTRATE; LEVONORGESTREL; MELOXICAM; MOMETASONE FUROATE; PARACETAMOL; PIOGLITAZONE; PROCATEROL; PSEUDOEPHEDRINE; SALBUTAMOL; SENNA EXTRACT; SERRATIOPEPTIDASE; TEPRENONE; TERFENADINE; THEOPHYLLINE; UNINDEXED DRUG; URSODEOXYCHOLIC ACID; VITAMIN;

ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ANOREXIA; ANTICHOLINERGIC EFFECT; ANXIETY DISORDER; ASTHMA; ATOPIC DERMATITIS; ATOPY; BRAIN HEMORRHAGE; CENTRAL NERVOUS SYSTEM DEPRESSION; CLINICAL TRIAL; COLD SENSATION; COLITIS; CONSTIPATION; CYSTITIS; DIARRHEA; DIPLOPIA; DIZZINESS; DROWSINESS; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRY NOSE; DYSURIA; ECZEMA; EDEMA; ERYTHEMA; EUPHORIA; FACE EDEMA; FATIGUE; FEVER; FLUSHING; GASTRITIS; GASTROESOPHAGEAL REFLUX; HEADACHE; HEART PALPITATION; HEARTBURN; HIRSUTISM; HISTAMINE RELEASE; HOT FLUSH; HUMAN; INSOMNIA; LASSITUDE; LEUKOPENIA; LIVER DISEASE; MALAISE; MASTALGIA; MENSTRUAL IRREGULARITY; MENSTRUATION DISORDER; META ANALYSIS; METEORISM; MICTURITION DISORDER; NAUSEA; NEPHRITIS; NERVOUSNESS; PROTEINURIA; PRURITUS; RASH; REVIEW; RIGOR; SEDATION; SIDE EFFECT; SOMNOLENCE; STOMATITIS; THROMBOCYTOPENIA; TINNITUS; TREMOR; URINARY FREQUENCY; URINARY TRACT INFECTION; URINE INCONTINENCE; URINE RETENTION; VISUAL IMPAIRMENT; VOMITING; XEROSTOMIA;

DIBENZAZEPINES; HISTAMINE ANTAGONISTS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMIDAZOLES; MOLECULAR STRUCTURE;

EID: 4644330528     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2004.40.8.850470     Document Type: Review

References (26)

1. Hardman, J.G., Limbird, L., Gilman, A.G. The Pharmacological Basis of Therapeutics, 10th ed. McGraw-Hill, New York 2001.
2. Bovet, D. Introduction to antihistamine agents and Antergan derivatives. Ann NY Acad Sci 1950, 50: 1089-126.
3. Walther, G., Daniel, H., Bechtel, W.D., Brandt, K. New tetracyclic guanidine derivatives with H1-antihistaminic properties. Chemistry of epinastine. Arzneimittelforschung 1990, 40: 440-6.
4. Fugner, A., Bechtel, W.D., Kühn, F.J., Mierau, J. In vitro and in vivo studies of the non-sedating antihistamine epinastine. Arzneimittelforschung 1988, 38: 1446-53.
5. Ishiguro, N., Nozawa, T., Tsujihata, A. et al. Influx and efflux transport of H1-antagonist epinastine across the blood-brain barrier. Drug Metab Dispos 2004, 32: 519-24.
6. Ohtani, H., Kotaki, H., Sawada, Y., Iga, T. Quantitative determination of epinastine in plasma by high-performance liquid chromatography. Chromatogr B Biomed Appl 1996, 683: 281-4.
7. Kishimoto, W., Hiroi, T., Sakai, K., Funae, Y., Igarashi, T. Metabolism of epinastine, a histamine H1 receptor antagonist, in human liver microsomes in comparison with that of terfenadine. Res Commun Mol Pathol Pharmacol 1997, 98: 272-92.
8. Kohyama, T., Takizawa, H., Akiyama, N., Sato, M., Kawasaki, S., Ito, K. A novel antiallergic drug epinastine inhibits IL-8 release from human eosinophils. Biochem Biophys Res Commun 1997, 230: 125-8.
9. Tasaka, K. Epinastine: An update of its pharmacology, metabolism, clinical efficacy and tolerability in the treatment of allergic diseases. Drugs Today 2000, 36: 735-57.
10. Kamei, C., Mio, M., Kitazumi, K. et al. Antiallergic effect of epinastine on immediate hypersensitivity reactions: (II). Antagonistic effect of epinastine on chemical mediators, mainly antihistaminic and anti-PAF effects, Immunopharmacol Immunotoxicol 1992, 14: 207-18.
11. Matsukura, M., Yajima, A., Yamazaki, F., Yudate, T., Yamada, H., Tezuka, T. Epinastine inhibits eosinophil chemotaxis and adhesion molecules in atopic dermatitis. Skin Pharmacol Appl Skin Physiol 2003, 16: 405-410.
12. Whitcup, S.M., Bradford, R., Lue, J., Schiffman, R.M., Abelson, M.B. Efficacy and tolerability of ophthalmic epinastine: A randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis. Clin Ther 2004, 26: 29-34.
13. Abelson, M.B., Gomes, P., Crampton, H.J., Schiffman, R.M., Bradford, R.R., Whitcup, S.M. Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis. Clin Ther 2004, 26: 35-47.
14. Schilling, J.C., Adamus, W.S., Kuthan, H. Antihistaminic activity and side effect profile of epinastine and terfenadine in healthy volunteers, Int J Clin Pharmacol Ther Toxicol 1990, 28: 493-97.
15. Chachin, M., Katayama, Y., Yamada, M. et al. Epinastine, a nonsedating histamine H1 receptor antagonist, has a negligible effect on HERG channel. Eur J Pharmacol 1999, 374: 457-60.
16. Roehrs, T., Zwyghuizen-Doorenbos, A., Roth, T. Sedative effects and plasma concentrations following single dose of triazolam, diphenhydramine, ethanol, and placebo. Sleep 1993, 16: 301-5.
17. Food and Drug Administration. FDA reviews antihistamine mouse study. National Press Office (May 17, Rockville, Md) 1994. Talk Paper.
18. Edwards, R., Biriell, C. Harmonisation in pharmacovigilance. Drug Saf 1994, 10: 93-102.
19. Bate, A., Lindquist, M., Edwards, I.R. et al. A bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 1998, 54: 315-21.
20. Fraunfelder, F.W., Fraunfelder, F.T. Bisphosphonates and ocular side effects. N Engl J Med 2003, 348: 1187-8.
21. Fraunfelder, F.W., Fraunfelder, F.T. Topiramate-associated acute, bilateral, secondary angle-closure glaucoma. Ophthalmology 2004, 111: 109-11.
22. Fraunfelder, F.W., Fraunfelder, F.T. Isotretinoin and intracranial hypertension. Ophthalmology 2004, 111: 1248-50.
23. Fraunfelder, F.W., Fraunfelder, F.T. Adverse ocular effects from over-the-counter lice shampoo. Arch Ophthalmol 2003, 121: 1790-1.
24. Fraunfelder, F.T., Fraunfelder, F.W. Drug-Induced Ocular Side Effects, 5th ed. Butterworth-Heinemann, Woburn, Mass 2001, 824.
25. Fraunfelder, F.W., Solomon, J., Druker, B.J., Esmaeli, B., Kuyl, J. Side effects associated with imatinib mesylate (Gleevec). J Ocular Pharmacol Therapeutics 2003, 19: 371-5.
26. Grant, W.M., Loeb, D.R. Effect of locally applied antihistamine drugs on normal eyes. Arch Ophthalmol 1948, 39: 553-4.